In vitro Synergistic and Bactericidal Effects of Aztreonam in Combination with Ceftazidime/ Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against Dual-Carbapenemase-Producing Enterobacterales
Dual-carbapenemase-producing <i>Enterobacterales</i> posed a significant threat to clinical anti-infection treatment. However, the combination of ATM with innovative <i>β</i>-lactam/β-lactamase inhibitor compounds had proven to be an effective treatment option.
Authors
- Yunsong Yu (ORCID: https://orcid.org/0000-0003-2903-918X)
- Ying Fu (ORCID: https://orcid.org/0000-0003-1177-0871)
- Jun Zhang (ORCID: https://orcid.org/0000-0002-2613-3165)
- Yufeng Zhu
- Qiong Chen (ORCID: https://orcid.org/0009-0005-3126-8178)
- Feng Zhao (ORCID: https://orcid.org/0000-0003-0850-9357)
- Bingyan Yao
Institutions
- Sir Run Run Shaw Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou Xixi hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/idr.s474150
- Citations
- 3
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.51
Funders
- Xinjiang Production and Construction Corps
- Science and Technology Program of Zhejiang Province